And you are right. We can be disappointed/upset with the fact that Denner is not being communicative with shareholders but the group even before KM and PWO got us into this mess which is like being caught in a black hole. For me it still boils down to one difference, and that is that he has his own money (a good amount of it) in this thing.
I would love to see average Day on Therapy data from the company but I would argue compliance rate is pretty high, especially if you have had a major coronary event. I would argue compliance, while not as high as statins, will be a fairly large percentage of that. Just my opinion.
Market Data 
Markets 
AI
